# Aspen reviews (2026): GLP-1 telehealth sellers | This GLP Both molecules cost the same here, every dosage costs the same, and the vial carries an additive the trials never measured. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/aspen-health Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 One rate, either molecule # Aspen review Both molecules cost the same here, every dosage costs the same, and the vial carries an additive the trials never measured. ## The verdict Aspen publishes as low as $179 a month for a compounded GLP-1 with glycine or B12. The same figure covers both molecules. All dosages are stated at one price, across 51 jurisdictions. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection Dose pricing Flat across doses States 51 From From $179/mo Prescription Required Compounded Yes — not FDA-approved Availability 51 jurisdictions Aspen sells a compounded GLP-1 injection with an additive, describing a semaglutide path and a tirzepatide path but publishing one figure for both. Coverage runs to 51 jurisdictions. 1. ## Who writes the prescription, and what do they see? A prescription precedes dispensing. The pages describe the paths and the price rather than the clinician or the review schedule behind them. Declining to charge more for the dual agonist is unusual and it removes a decision most sellers monetize. The cost of that simplicity is that the two paths are not priced separately, so a reader cannot see what either would cost alone. 2. ## What happens when the dose goes up? All dosages are the same price, stated plainly. That answers the escalation question completely, and it is the strongest disclosure on the page. 3. ## What the price includes Six months at $179 is $1,074, and the flat-dosage statement makes that a real total rather than an opening one. The figure is still qualified as low as, so something unpublished can lift it. 4. ## What it claims, and what it cites The preparation is compounded with glycine or B12 rather than being the molecule alone. A pharmacy makes it to order and no agency reviews it before dispensing. The trials behind [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) and [tirzepatide](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) studied neither additive. ## Where it holds up, and where it does not - Strength: A single figure spans both molecules - Strength: All dosages priced identically - Strength: Coverage in 51 jurisdictions - Strength: The additive is disclosed on the card - Limitation: The two paths are not priced separately - Limitation: The figure is still an as-low-as - Limitation: No trial measured the additive - Limitation: The pharmacy behind it is not identified ## What the evidence says about this kind of treatment The assessment above is about Aspen. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants the escalation question closed and does not need the two molecules priced apart. Wrong for A reader who wants plain semaglutide without anything else in the vial. ## The evidence behind what Aspen prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Aspen compares | Seller | Who it suits | Go | | --- | --- | --- | | Auren Rx | Readers who want a cancel-anytime subscription with the no-commitment rate printed beside it | | | Aspire Health | Readers who want the dose stated beside the vial and will do the arithmetic | | | Balanced Hormone Health | Readers who would rather see a dose increase priced than hidden in a monthly figure | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Hers](https://thisglp.com/reviews/hers) [Heva Health](https://thisglp.com/reviews/heva-health) [Hims](https://thisglp.com/reviews/hims) [Idgie Health](https://thisglp.com/reviews/idgie-health) [Immortals](https://thisglp.com/reviews/immortals) [Independent Wellness](https://thisglp.com/reviews/independent-wellness) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is the dual agonist priced higher? No. Aspen publishes one figure and describes both paths under it. What happens when the dose goes up? Nothing, according to the seller: all dosages are stated at the same price. What is glycine or B12 doing in it? It is part of the compounded preparation Aspen sells. The trials behind either molecule tested the molecule alone. Is Aspen legit? Aspen is a GLP-1 telehealth sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is Aspen expensive compared with other GLP-1 telehealth sellers? Aspen publishes a starting figure of $179/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Aspen below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).